A detailed history of Macroview Investment Management LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Macroview Investment Management LLC holds 181 shares of DVAX stock, worth $2,132. This represents 0.0% of its overall portfolio holdings.

Number of Shares
181
Previous 181 -0.0%
Holding current value
$2,132
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$13.09 - $14.98 $3,913 - $4,479
-299 Reduced 62.29%
181 $2,000
Q3 2023

Oct 26, 2023

BUY
$12.64 - $14.99 $6,067 - $7,195
480 New
480 $7,000
Q1 2022

May 02, 2022

SELL
$9.75 - $14.44 $12,343 - $18,281
-1,266 Closed
0 $0
Q4 2021

Jan 25, 2022

BUY
$13.17 - $20.94 $16,673 - $26,510
1,266 New
1,266 $18,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.49B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Macroview Investment Management LLC Portfolio

Follow Macroview Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Macroview Investment Management LLC with notifications on news.